In addition, in many other cancer types such as ACC, BLCA, MESO, UVM, LIHC, and UCS, high YTHDF1 expression meant worse prognosis, which proved that YTHDF1 was a potential prognostic pan-cancer biomarker. Here, YTHDF1 is linked to cancer.